Browse recent medication, recall, and health-related stories.
Page 39 of 51
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) USA News Group News Commentary NEW YORK, July 23, 2026 /PRNewswire/ -- For years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk about...
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) USA News Group News Commentary NEW YORK, July 23, 2026 /PRNewswire/ -- For years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk about...
TAIPEI and SAN CARLOS, Calif., July 23, 2026 /PRNewswire/ -- AcroCyte Therapeutics Inc. announced today that it has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA‐H) to advance scalable human organoid technologies for regenerative medicine...
UNC Health Southeastern will soon be at the forefront of a groundbreaking medical research project, one that began with a simple but remarkable observation made in the hospital’s Special Care Nursery.
Proven track record of consistent high quality confirmed at Pace® Life Sciences
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
The U.S. Food & Drug Administration walked back a notification that lettuce from Taylor Farms tested positive for the Cyclospora that has been causing illness across the country in recent weeks.
Global Health Advances: A Dive into Breakthroughs and Challenges Devdiscourse Global Health Updates: From Bird Flu to Foodborne Outbreaks Devdiscourse Health News Round-Up: Global Flu, Drug Innovations, and Outbreaks Update Devdiscourse Global Health Updates: Tackling New Outbreaks and Drug Developments Devdiscourse Global Health Updates: From Bird Flu in New Zealand to Drug Developments in India Devdiscourse
The U.S. Food and Drug Administration (FDA) on Sunday said that a follow-up review of a lettuce sample collected from Taylor Farms determined it was a false positive for cyclospora, the parasitic illness that has caused a nationwide outbreak. The FDA previously stated on Saturday that the shredded lettuce sample provided by Taylor Farms from...
TAIPEI and SAN CARLOS, Calif., July 23, 2026 /PRNewswire/ -- AcroCyte Therapeutics Inc. announced today that it has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA‐H) to advance scalable human organoid technologies for regenerative medicine...
UNC Health Southeastern will soon be at the forefront of a groundbreaking medical research project, one that began with a simple but remarkable observation made in the hospital’s Special Care Nursery.
Global Health Advances: A Dive into Breakthroughs and Challenges Devdiscourse Global Health Updates: From Bird Flu to Foodborne Outbreaks Devdiscourse Health News Round-Up: Global Flu, Drug Innovations, and Outbreaks Update Devdiscourse Global Health Updates: Tackling New Outbreaks and Drug Developments Devdiscourse Global Health Updates: From Bird Flu in New Zealand to Drug Developments in India Devdiscourse
The U.S. Food and Drug Administration (FDA) on Sunday said that a follow-up review of a lettuce sample collected from Taylor Farms determined it was a false positive for cyclospora, the parasitic illness that has caused a nationwide outbreak. The FDA previously stated on Saturday that the shredded lettuce sample provided by Taylor Farms from...